126 related articles for article (PubMed ID: 37652400)
1. DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
Hsu Lin L; Allison DHR; Turashvili G; Vasudevaraja V; Tran I; Serrano J; Weigelt B; Ladanyi M; Abu-Rustum NR; Snuderl M; Chiang S
Mod Pathol; 2023 Nov; 36(11):100321. PubMed ID: 37652400
[TBL] [Abstract][Full Text] [Related]
2. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
Schultheis AM; Ng CK; De Filippo MR; Piscuoglio S; Macedo GS; Gatius S; Perez Mies B; Soslow RA; Lim RS; Viale A; Huberman KH; Palacios JC; Reis-Filho JS; Matias-Guiu X; Weigelt B
J Natl Cancer Inst; 2016 Jun; 108(6):djv427. PubMed ID: 26832770
[TBL] [Abstract][Full Text] [Related]
3. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?
Weng CH; Wu RC; Chen SJ; Chen HC; Tan KT; Lee YS; Huang SS; Yang LY; Wang CJ; Chou HH; Chao AS; Chao A; Lai CH
J Mol Med (Berl); 2021 Jul; 99(7):959-966. PubMed ID: 33768299
[TBL] [Abstract][Full Text] [Related]
4. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
5. Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology.
Chao A; Wu RC; Jung SM; Lee YS; Chen SJ; Lu YL; Tsai CL; Lin CY; Tang YH; Chen MY; Huang HJ; Chou HH; Huang KG; Chang TC; Wang TH; Lai CH
Gynecol Oncol; 2016 Oct; 143(1):60-67. PubMed ID: 27498588
[TBL] [Abstract][Full Text] [Related]
6. Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.
Anglesio MS; Wang YK; Maassen M; Horlings HM; Bashashati A; Senz J; Mackenzie R; Grewal DS; Li-Chang H; Karnezis AN; Sheffield BS; McConechy MK; Kommoss F; Taran FA; Staebler A; Shah SP; Wallwiener D; Brucker S; Gilks CB; Kommoss S; Huntsman DG
J Natl Cancer Inst; 2016 Jun; 108(6):djv428. PubMed ID: 26832771
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
Cybulska P; Paula ADC; Tseng J; Leitao MM; Bashashati A; Huntsman DG; Nazeran TM; Aghajanian C; Abu-Rustum NR; DeLair DF; Shah SP; Weigelt B
Gynecol Oncol; 2019 Sep; 154(3):516-523. PubMed ID: 31340883
[TBL] [Abstract][Full Text] [Related]
8. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
10. The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.
Nishimura S; Ito YM; Tsuda H; Ohnishi Y; Kataoka F; Nomura H; Chiyoda T; Suzuki A; Susumu N; Aoki D; Hatae M
Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):67-72. PubMed ID: 19815329
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach.
Wu RC; Veras E; Lin J; Gerry E; Bahadirli-Talbott A; Baras A; Ayhan A; Shih IM; Wang TL
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162652
[TBL] [Abstract][Full Text] [Related]
12. Methylation profiles of endometrioid and serous endometrial cancers.
Seeber LM; Zweemer RP; Marchionni L; Massuger LF; Smit VT; van Baal WM; Verheijen RH; van Diest PJ
Endocr Relat Cancer; 2010 Sep; 17(3):663-73. PubMed ID: 20488783
[TBL] [Abstract][Full Text] [Related]
13. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
Zhan X; Li L; Wu M; Lang J
Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
[TBL] [Abstract][Full Text] [Related]
14. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H
Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
[TBL] [Abstract][Full Text] [Related]
15. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.
McConechy MK; Ding J; Senz J; Yang W; Melnyk N; Tone AA; Prentice LM; Wiegand KC; McAlpine JN; Shah SP; Lee CH; Goodfellow PJ; Gilks CB; Huntsman DG
Mod Pathol; 2014 Jan; 27(1):128-34. PubMed ID: 23765252
[TBL] [Abstract][Full Text] [Related]
16. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
17. CTNNB1 p.L31P mutation in an ovarian endometrioid carcinoma with synchronous uterine endometrioid carcinoma.
Pecorella I; Coppa A; Nicolussi A; Manganaro L; Fiorentin F; Palaia I; Muzii L
Pathol Res Pract; 2020 Dec; 216(12):153260. PubMed ID: 33120166
[TBL] [Abstract][Full Text] [Related]
18. Does synchronous endometrioid endometrial cancer have any prognostic effect on Stage I endometrioid ovarian cancer?
Narin MA; Karalok A; Basaran D; Ureyen I; Turkmen O; Turan T; Tulunay G
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():113-6. PubMed ID: 27017531
[TBL] [Abstract][Full Text] [Related]
19. Mesonephric-like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix.
Kommoss FK; Lee CH; Tessier-Cloutier B; Gilks CB; Stewart CJ; von Deimling A; Köbel M
J Pathol; 2024 Jan; 262(1):4-9. PubMed ID: 37850576
[TBL] [Abstract][Full Text] [Related]
20. Synchronous tumours of the female reproductive tract.
Gilks CB; Kommoss F
Pathology; 2018 Feb; 50(2):214-221. PubMed ID: 29249564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]